CT, NG, MG Targets

2-30℃ for 18 months

400 Copies/mL.

urine, male urethral swab, female cervical swab, and female vaginal swab samples

Open real-time PCR platforms equipped with FAM, VIC/HEX, ROX, and Cy5 detection channels, including but not limited to ABI 7500, Roche LightCycler 480, Bio-Rad CFX96, QuantStudio™ 5, SLAN 96, Molarray MA-6000, Rotor-Gene Q, and Mic qPCR Cycler.

There is no cross-reactivity between this kit and other genitourinary tract infection pathogens such as high-risk Human papillomavirus type 16, Human papillomavirus type 18, Herpes simplex virus type Ⅱ, Treponema pallidum, Ureaplasma urealyticum, Mycoplasma hominis, Staphylococcus epidermidis, Escherichia coli, Gardnerella vaginalis, Candida albicans, Trichomonas vaginalis, Lactobacillus crispatus, Adenovirus, Cytomegalovirus, Group B Streptococcus, Human immunodeficiency virus, Lactobacillus casei and human genomic DNA, etc.

The interfering samples which contain bilirubin (0.2mg/mL), cervical mucus (10%), white blood cells (10⁹ cells/mL), mucin (60mg/mL), whole blood (10%), semen (10%), levofloxacin (0.2mg/mL), erythromycin (0.3mg/mL), penicillin (0.5mg/mL), azithromycin (0.3mg/mL), Jieryin lotion (10%), Fuyanjie lotion (10%) will not affect the test results.

The %CV of repeatability and reproducibility are all ≤5.0% of CT, NG, MG Targets.